Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
The GLP1R/GIPR dual agonist NNC 00902746 (Novo Nordisk) significantly improved hemoglobin A1c (A1c) in T2DM (a reduction of 0.96% vs placebo) over a 12-week period, accompanied by a reduction in body weight
However, the pharmacy provider reportedly terminated the integration three months later
Retatrutide Dose for Weight Loss When initiating research protocols for retatrutide, it is advisable to start with a minimal dose of 1mg/weekly
After Your Appointment Keep the treated area dry for 24 hours
Suitability considerations: Consistent with class precedents for GLP-1-based therapies, retatrutide would not be expected to be suitable during pregnancy or breastfeeding, and paediatric data are currently lacking
US$ 29.49
US$ 23.81
US$ 26.74
